Document is current
Any future updates will be listed below
-
Authors
Shi, Meiqi
Chen, Ping
Cui, Bin
Yao, Yuanhu
Wang, Juanyi
Zhou, Tong
Wang, Li
- License Information
-
More Information
Article History
Received: 25 April 2024
Revised: 6 September 2024
Accepted: 16 September 2024
First Online: 10 October 2024
Competing interests
: This study was funded by the Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Jiangsu, China. The authors declare no competing interests.
: The study protocol was reviewed and approved by the Ethics Committee of Jiangsu Cancer Hospital (approval no.: 2019 [053]). Written informed consent was obtained from all patients before enrolment.
